1547P Clinical outcomes of patients with acquired resistance to checkpoint inhibitors in melanoma, renal cell carcinoma and non-small cell lung cancer.
Saved in:
| Title: | 1547P Clinical outcomes of patients with acquired resistance to checkpoint inhibitors in melanoma, renal cell carcinoma and non-small cell lung cancer. |
|---|---|
| Authors: | Syberg, M.J.1 (AUTHOR), Andersen, R.1 (AUTHOR), Presti, M.2 (AUTHOR), Bjoernhart, B.3 (AUTHOR), Moller, A.K.H.1 (AUTHOR), Frank, M.S.4 (AUTHOR), Schmidt, H.5 (AUTHOR), Henriksen, J.R.3 (AUTHOR), Bjerrum, A.6 (AUTHOR), Luczak, A.A.7 (AUTHOR), Wahlstroem, S.8 (AUTHOR), Zitnjak, D.9 (AUTHOR), Svane, I.M.2 (AUTHOR), Fristrup, N.5 (AUTHOR), Kristiansen, C.10 (AUTHOR), Persson, G.1 (AUTHOR), Bastholt, L.3 (AUTHOR), Pohl, M.6 (AUTHOR), Ellebaek, E.2 (AUTHOR), Donia, M.2 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS924-S924. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.2178 |
